Success Metrics

Clinical Success Rate
77.8%

Based on 7 completed trials

Completion Rate
78%(7/9)
Active Trials
1(9%)
Results Posted
43%(3 trials)
Terminated
2(18%)

Phase Distribution

Ph phase_4
4
36%
Ph phase_1
1
9%
Ph phase_2
4
36%
Ph phase_3
2
18%

Phase Distribution

1

Early Stage

4

Mid Stage

6

Late Stage

Phase Distribution11 total trials
Phase 1Safety & dosage
1(9.1%)
Phase 2Efficacy & side effects
4(36.4%)
Phase 3Large-scale testing
2(18.2%)
Phase 4Post-market surveillance
4(36.4%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

77.8%

7 of 9 finished

Non-Completion Rate

22.2%

2 ended early

Currently Active

1

trials recruiting

Total Trials

11

all time

Status Distribution
Active(1)
Completed(7)
Terminated(2)
Other(1)

Detailed Status

Completed7
Terminated2
unknown1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
1
Success Rate
77.8%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (9.1%)
Phase 24 (36.4%)
Phase 32 (18.2%)
Phase 44 (36.4%)

Trials by Status

completed764%
terminated218%
unknown19%
recruiting19%

Recent Activity

1 active trials
Showing 5 of 11
completedphase_1

Dose-Finding Study of Intranasal Midazolam for Procedural Sedation in Children

NCT04586504
recruitingphase_4

IN Midazolam vs IN Dexmedetomidine vs IN Ketamine During Minimal Procedures in Pediatric ED

NCT05934669
terminatedphase_3

AGItated Patients Management: intraNASAL Midazolam vs Intramuscular Loxapine

NCT05324852
completedphase_2

Intranasal Versus Nebulized Midazolam in Behaviuor Modification of Preschool Children Undergoing Dental Treatment

NCT05883150
unknownphase_3

Nebulized Lidocaine and Intranasal Midazolam for NGT Insertion in Children

NCT04571879
View all 11 trials

Clinical Trials (11)

Showing 11 of 11 trials
NCT04586504Phase 1

Dose-Finding Study of Intranasal Midazolam for Procedural Sedation in Children

Completed
NCT05934669Phase 4

IN Midazolam vs IN Dexmedetomidine vs IN Ketamine During Minimal Procedures in Pediatric ED

Recruiting
NCT05324852Phase 3

AGItated Patients Management: intraNASAL Midazolam vs Intramuscular Loxapine

Terminated
NCT05883150Phase 2

Intranasal Versus Nebulized Midazolam in Behaviuor Modification of Preschool Children Undergoing Dental Treatment

Completed
NCT04571879Phase 3

Nebulized Lidocaine and Intranasal Midazolam for NGT Insertion in Children

Unknown
NCT04608734Phase 2

Buccal Versus Intranasal Route of Administration of Midazolam Spray in Behavior Management of Pre-School Patients

Completed
NCT04263844Phase 4

Intranasal Dexmedetomidine Versus Intranasal Midazolam for Emergence Delirium Prevention

Completed
NCT01948908Phase 2

Volumes of Administration for Intranasal Midazolam

Completed
NCT02447289Phase 4

Midazolam and Ketamine Effect Administered Through the Nose for Sedation of Children for Dental Treatment

Completed
NCT02206776Phase 2

Randomized Controlled Trial of Intranasal Ketamine vs. Intranasal Midazolam in Individuals With OCD

Terminated
NCT02635282Phase 4

IN Ketamine Vs IN Midazolam and Fentanyl for Abscess I&D

Completed

All 11 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
11